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Trends and disparities
in osteoarthritis prevalence
among US adults, 2005–2018
Yingke Xu1,2 & Qing Wu1,2*
Studies reporting trends and disparities of osteoarthritis (OA) in the United States are limited. We
aimed to examine trends and disparities of OA prevalence among US adults, from 2005 to 2018.
Continuous National Health and Nutrition Examination Survey (NHANES) data from 2005–2006 to
2017–2018 were analyzed. Age-adjusted and self-reported OA prevalence, stratified by race/ethnicity
and socioeconomic status (SES), was calculated separately for men and women. The linear trend
and the association between the survey cycles and OA prevalence were assessed. Age-adjusted and
self-reported OA prevalence linearly increased in the seven survey cycles (both Plinear trend ≤ 0.0002)
in men and women. Non-Hispanic Caucasians (both Plinear trend ≤ 0.0001) in both genders and NonHispanic African Americans women (Plinear trend ≤ 0.0001) had significantly increasing linear trends
in OA prevalence. In addition, people with lower SES had a lower age-adjusted prevalence of selfreported OA when compared to those with higher SES. The increasing linear trends still existed among
both men and women after adjusting for multiple confounders (both Plinear trend ≤ 0.002). There were
significant rising trends and disparities in self-reported OA prevalence among US men and women
between 2005 and 2018.
Osteoarthritis (OA) is a slowly progressive disease that affects joint systems in humans1. This disease negatively
influences millions of individuals worldwide and is a major cause of pain, comorbidity, and m
 ortality2. Typically,
people with OA will experience lower employment than those without OA since the disease is a leading cause
of disability3. OA is the most costly condition for privately insured patients in this country, accounting for over
$6.3 billion in healthcare e xpenses4. The number of US adults with arthritis is expected to reach 78 million in
20405. As the most common form of arthritis, OA is associated with an increased economic burden for both
individuals and the healthcare system due to its high prevalence6.
A limited number of studies have explored the trends and disparities in OA prevalence among US a dults7–9.
Dr. Park et al. reported that OA’s overall prevalence had doubled from 1999 to 2 0147. Another study suggested
that Non-Hispanic African Americans had significantly greater knee OA odds than Non-Hispanic Caucasians
during 1991–19949. However, OA’s prevalence trends in the US adult population and within gender and socioeconomic status (SES) subgroups remain unknown after 2014. Notably, the trend in multivariable-adjusted OA
prevalence among US adults since then has not been reported in any existing literature.
Therefore, we aimed to examine the trend of OA prevalence in men and women and within race/ethnicity
and SES groups from 2005 to 2018. Our study not only included new data after 2014, but we also examined sexspecific trends in OA prevalence during 2005–2018, after adjusting for race, SES, and related risk factors. Our
findings will provide a more comprehensive understanding of recent OA trends and disparities in US adults.

Methods

Study design. Data from 7 discrete 2-year cycles (2005–2006 through 2017–2018) of the continuous
National Health and Nutrition Examination Survey (NHANES) were used to examine the trends of OA prevalence in US adults. NHANES is a nationally representative survey for evaluating the US population’s health and
nutrition status at defined periods of time. The plan of operation and sampling scheme are extensively described
elsewhere10. But briefly stated, the Centers for Disease Control and Prevention employs an intricate, multistage probability sampling design for examining a nationally representative sample across the country every
2 years10,11. The data is collected through home interviews and physical examinations. NHANES interviews
contain information about demographic, socioeconomic, dietary, and health-related parameters. The physical
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examination includes medical, dental, and physiological measurements; the detailed methodology and protocols have also been described e lsewhere12. To produce reliable statistics, NHANES oversamples persons 60 and
older who are of African American and Hispanic ethnicity. NHANES study protocol has been approved by the
National Center for Health Statistics Research Ethics Review Board. Written informed consent was obtained
for all adult participants. All research was performed in accordance with the Declaration of Helsinki. Sample weights in NHANES have been constructed to adjust for non-response, oversampling, and non-coverage.
Because of the thoroughness of its research methodology, NHANES data have been widely used over the years
to reliably assess many diseases’ prevalence and risk factors. NHANES only collects osteoarthritis information
among adults aged 20 or older, which consists of the analytic population in the current study.

Variables. Since self-reported, doctor-diagnosed arthritis is the most commonly used case definition for

prevalence and other epidemiological studies13–15. Each NAHNES participant was defined as having OA if he/
she answered: “yes” to the question “Has a doctor or other health professional ever told you that you had arthritis?” and “osteoarthritis” to the question “Which type of arthritis was it?” Demographic variables, including age,
gender, and race/ethnicity, were ascertained by questionnaire. For the race/ethnicity groups, Mexican American and Other Hispanic were merged into Hispanic, and the remaining groups were Non-Hispanic Caucasian,
Non-Hispanic African American, and Non-Hispanic Other, respectively. The educational attainment and family
poverty income ratio (PIR) of participants were chosen as SES indicators. Educational attainment was categorized as less than high school, high school graduate/GED, some college, and college graduate or a bove16. PIR was
computed as a ratio of the mid-point of the observed family-income category to the family’s appropriate poverty threshold in a given calendar year, as set by the US Census Bureau17. Individuals were stratified into three
levels based on their PIR: PIR < 1.3 (low income), 1.3 ≤ PIR < 3.5 (middle income), and ≥ 3.5 (high income)18.
The cutoff point for participating in the Supplemental Nutrition Assistance Program is PIR = 1.3, so individuals with PIR < 1.3 were classified to the low-income group; PIR ≥ 3.5 provides relatively equal sample sizes for
each of the three income g roups18, thus people with PIR ≥ 3.5 were classified to high-income group and those
with 1.3 ≤ PIR < 3.5 were the middle-income group. OA-related risk factors were considered and selected based
on existing literature and on availability in the NHANES data. Weight s tatus19, smoking status20, and physical
activity21 were included in the current study. Participants were categorized as obese if body mass index (BMIweight in kilograms divided by height in meters squared) was greater than 3 022,23. Smoking status was categorized into current smokers, former smokers, and non-smokers24. Current smokers were respondents who had
smoked at least 100 cigarettes during their lifetime and reported smoking either every day or some days at the
time of the interview. Former smokers were those who reported smoking 100 cigarettes during their lifetime
but currently did not smoke. Otherwise, participants were classified as non-current-smokers. Physical activity
was categorized as inactive and active. Participants who were sedentary or only did basic activities, which refers
to the light-intensity activities like standing and walking slowly, were considered to be inactive; otherwise, the
individuals were classified as active25.

Statistical analyses. Sampling weight was used to account for the complex survey design (e.g., unequal
probabilities of selection) during analysis. Estimates were age-adjusted by the direct method to the 2000 US Census population26. Age-adjusted OA prevalence in every survey cycle was estimated by race/ethnicity, education
level, and PIR level for each gender. Standard errors, which were employed to construct confidence intervals,
were estimated using Taylor series linearization. Testing for a difference of age-adjusted prevalence between
groups was done using the pairwise t-test. Linear trends during the seven survey cycles were assessed by gender,
race, and SES using orthogonal polynomial contrasts. JoinPoint Software (National Cancer Institute, Bethesda,
MD) was utilized to determine the slopes and find the inflection point and differences in slopes between the two
survey cycles by using piecewise linear regression27. If at least one significant change point was found, we report
the year the trend shifted; otherwise, we only report P for linear trend. The survey cycle was used as a categorical
variable in the analysis. OA prevalence was modeled as a function of the survey cycle after first adjusting for age
and then with further adjustments for age, race, educational attainment, and PIR. We performed the analysis
using the completed data, and missing data were excluded from the study. Since all variables had < 10% missing
data, using complete data is unlikely to cause a biased estimate. Data analysis was conducted using procedure
PROC SURVEY of SAS 9.4 (SAS Institute, Cary, NC, USA).

Results

Characteristics of the analytic sample. A total of 34,171 eligible participants in NHANES from 2005–
2006 to 2017–2018 were included for the analysis; 11.03% of them had OA. The weighted characteristics of participants are presented in Table 1. From 2005–2006 to 2017–2018, the mean (SD) age of participants increased
from 46.20 (0.75) years to 48.10 (0.65) years. Additionally, the proportion of Hispanics increased from 11.05 to
14.48%, whereas the percentage of Non-Hispanic Caucasians decreased from 72.13 to 64.27%. The percentage of
people having less than a high school diploma decreased during 2005–2018, while the percentage of participants
who graduated from college or above increased. The distribution of risk factors of OA for men and women is
shown in Supplementary Table 1.
OA prevalence trends by gender.

The gender-specific and age-adjusted prevalence of self-reported OA
in 2005–2018 appears in Fig. 1. Overall, women had a significantly higher age-adjusted OA prevalence than
men (P-value < 0.0001). OA’s age-adjusted prevalence among men increased from 7.25 (95% CI 6.21–8.28%) to
11.56% (95% CI 10.22–12.90%) in 2005-2014, and then decreased in 2015-2018. For women, the age-adjusted
OA prevalence increased from 10.81% (95% CI 9.51–12.09%) to 17.39% (95% CI 15.52–19.26%) during 2005–
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2005–2006
(N = 4459)

2007–2008
(N = 5084)

2009–2010
(N = 5399)

2011–2012
(N = 4801)

2013–2014
(N = 5094)

2015–2016
(N = 4846)

2017–2018
(N = 4488)

Age, mean (SD)
(years)

46.20 (0.75)

46.51 (0.43)

46.84 (0.51)

47.04 (0.88)

47.38 (0.38)

47.59 (0.57)

48.10 (0.65)

Women, No.
(weighted %)

2326 (51.94)

2585 (51.82)

2785 (51.96)

2442 (51.82)

2661 (51.82)

2518 (52.17)

2320 (51.77)

Race, No. (weighted %)
Hispanica

1012 (11.05)

1388 (12.73)

1439 (12.72)

944 (13.90)

1072 (13.89)

1447 (14.69)

954 (14.48)

NH-Caucasian

2240 (72.13)

2436 (70.23)

2691 (69.54)

1822 (67.47)

2240(66.75)

1647 (65.16)

1637 (64.27)

NH-African
American

1026 (11.51)

1052 (11.04)

975 (11.11)

1243 (11.08)

1048 (11.36)

1010 (11.00)

1019 (10.83)

181(5.31)

208 (6.00)

294 (6.63)

792 (7.55)

734 (8.00)

742 (9.15)

878 (10.42)

NH-other

Education level, No. (weighted %)
< High school

1205 (17.28)

1545 (20.16)

1474 (18.31)

1082 (15.80)

1049 (14.66)

1099 (13.76)

829 (10.40)

High school graduate/GED

1065 (24.92)

1250 (25.07)

1242 (22.79)

1002 (19.87)

1141 (21.74)

1058 (20.72)

1081 (27.25)

Some college

1283 (31.40)

1318 (29.01)

1544 (30.52)

1470 (32.32)

1601 (33.12)

1459 (32.60)

1480 (31.22)

906 (26.40)

971 (25.76)

1139 (28.38)

1247 (32.01)

1303 (30.48)

1230 (32.92)

1098 (31.13)

≥ College
PIR, No. (weighted %)
< 1.3

1166 (17.18)

1551 (20.50)

1813 (21.68)

1724 (24.85)

1759 (24.79)

1567 (21.00)

1274 (20.06)

1.3–3.5

1757 (37.85)

1979 (35.01)

2023 (36.49)

1629 (34.08 )

1749 (34.34)

1924 (36.78)

1855 (35.92)

≥ 3.5

1536 (44.97)

1554 (44.49)

1561 (41.82)

1448 (41.07)

1586 (40.87)

1355 (42.21)

1359 (44.02)

Table 1.  Weighted characteristics of participants in seven National Health and Nutrition Examination Surveys
from 2005 to 2018. NH-Caucasian Non-Hispanic Caucasian, NH-African American Non-Hispanic African
American, NH-Other Non-Hispanic other, GED General Educational Development, PIR poverty income ratio.
a
Hispanic includes Mexican American and other Hispanic.
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Figure 1.  Age-adjusted prevalence of osteoarthritis by gender, 2005–2006 through 2017–2018.

2014, then decreased a little bit and then remained stable. A significant overall linear trend was observed for
both men and women (all P
 linear trend ≤ 0.0002). The Joinpoint analysis and piecewise regression analysis found no
inflection point during 2005–2018 for both men (slope = 1.06, P = 0.02) and women (slope = 1.03, P-value = 0.02).

OA prevalence by race in both genders. The age-adjusted self-reported OA prevalence by race/ethnic-

ity in men and women is presented in Fig. 2. Non-Hispanic Caucasian men had a higher age-adjusted prevalence
of OA than men from the Hispanic and Non-Hispanic African American groups (both P-values < 0.0001). In
comparison, Non-Hispanic women had a significantly higher OA prevalence than women in the other three
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Figure 2.  Age-adjusted prevalence of osteoarthritis by race in men and women, 2005–2006 through 2017–2018.
race/ethnicity groups (all P-values < 0.0001). In men, OA’s age-adjusted prevalence among Non-Hispanic Caucasians increased from 7.77% (95% CI 6.31–9.23%) to 14.01% (95% CI 12.52–15.51%) during 2005–2014. Then
it decreased to 10.45% (95% CI 8.35–12.52%) in 2015–2016 and remained in a steady state. In addition, a significant linear trend was observed among the Non-Hispanic Caucasian men in the seven cycles (Plinear trend < 0.0001);
the slope for this group was 1.03 (P-value = 0.04). In women, the age-adjusted OA prevalence of Non-Hispanic
Caucasians increased from 11.95% (95% CI 10.23–13.68%) to 20.76% (95% CI 18.47–23.06%) in 2005–2014,
and then remained approximately 18.5% from 2015 to 2018. OA’s prevalence among women in Hispanic, NonHispanic African American, and Non-Hispanic Other groups increased during 2005–2018. We observed a significant linear trend in all race/ethnicity groups except Non-Hispanic Other groups (all Plinear trend ≤ 0.02), and
no apparent change in OA prevalence over time ( slopeNon-Hispanic Caucasian = 1.02, P-value = 0.04; slopeHispanic = 0.95,
P-value = 0.005; slopeNon-Hispanic African American = 0.40, P-value = 0.03).

OA prevalence by SES in both genders. The pattern of the age-adjusted prevalence of self-reported OA,
stratified by education attainment in both men and women, is presented in Fig. 3. For men, the highest education
level (≥ college) had a higher prevalence than other groups (all P-values ≤ 0.01). However, significant increasing
linear trend were only observed among men with high school diploma/GED (Plinear trend = 0.01) in 2005-2018
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Figure 3.  Age-adjusted prevalence of osteoarthritis by education level in men and women, 2005–2006 through
2017–2018.

(slope = 0.65, P-value = 0.04). In men with high school diploma/GED, the adjusted OA prevalence increased in
2005–2018 from 5.37% (95% CI 3.38–7.37%) to 9.19% (5.86–12.52%). For women, age-adjusted OA prevalence
among those with the lowest education attainment (less than high school) was lower than in other groups (all
P-values ≤ 0.003). We observed significant linear trends among women in all education levels (all Plinear trend < 0.04,
slope<high school = 1.28, P-value = 0.02; slopehigh school/GED = 1.14, P-value = 0.004; slopesome college = 1.36, P-value = 0.02;
slope≥college = 0.88, P-value = 0.049). Specifically, age-adjusted OA prevalence among women with a high school
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Figure 4.  Age-adjusted prevalence of osteoarthritis by poverty income ratio level in men and women, 2005–
2006 through 2017–2018.

diploma/GED kept increasing during the seven survey cycles, from 10.81% (95% CI 8.74–12.89%) to 17.70%
(95% CI 12.40–23.00%).
The age-adjusted prevalence of self-reported OA by PIR for men and women is shown in Fig. 4. The men with
the lowest family income (PIR < 1.3) had a lower age-adjusted OA prevalence among the two PIR groups (both
P-values ≤ 0.0003). The age-adjusted prevalence of OA in this group increased from 4.51% (95% CI 3.51–5.51%)
to 7.21% (95% CI 5.47–8.95%) in 2005–2012, then remained stable at around 7.5% in the last three survey cycles.
Significant linear trends were observed among men with all PIR levels (all Plinear trend < 0.03; slopePIR<1.3 = 0.71,
P-value = 0.03; slope1.3≤PIR<3.5 = 0.77, P-value = 0.01; slopePIR≥3.5 = 0.53, P-value = 0.03). Women with the lowest
PIR (PIR < 1.3) had a significantly lower age-adjusted prevalence of OA than those people with the highest PIR
(P-value = 0.01). During the seven survey cycles, the prevalence fluctuated for women with the lowest family
income, but the overall pattern increased. Significant linear trends were observed in all the three PIR groups
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Odds Ratios (95% CI)
Sample size

Adjusted for age

Adjusted for age, race/ethnicity, educational attainment, PIR, obesity, smoking, and
physical activity

2005–2006

2133

1 (reference)

1 (reference)

2007–2008

2499

0.90 (0.68–1.20)

0.91 (0.69–1.19)

2009–2010

2614

1.03 (0.78–1.34)

1.01 (0.77–1.32)

2011–2012

2359

1.27 (0.97–1.66)

1.25 (0.96–1.64)

2013–2014

2433

1.78 (1.42–2.24)

1.76 (1.40–2.20)

2015–2016

2328

1.36 (1.03–1.79)

1.31 (0.99–1.74)

2017–2018

2168

1.46 (1.05–2.02)

1.43 (1.04–1.97)

2005–2006

2326

1 (reference)

1 (reference)

2007–2008

2585

1.08 (0.77–1.51)

1.10 (0.79–1.52)

2009–2010

2785

0.98 (0.78–1.23)

0.97 (0.78–1.21)

2011–2012

2442

1.41 (1.11–1.80)

1.43 (1.13–1.82)

2013–2014

2661

1.88 (1.52–2.32)

1.86 (1.49–2.32)

2015–2016

2518

1.70 (1.39–2.08)

1.70 (1.39–2.07)

2017–2018

2320

1.76 (1.31–2.35)

1.70 (1.31–2.38)

Survey cycle
Men

Women

Table 2.  Adjusted association between survey cycle and prevalence of osteoarthritis by gender, 2005–2006
through 2017–2018. PIR poverty income ratio.

among women (all P
 linear trend < 0.0001; slopePIR<1.3 = 1.33, P-value = 0.01; slope1.3≤PIR<3.5 = 1.06, P-value = 0.03;
s lopePIR≥3.5 = 1.24, P-value = 0.02).

OA prevalence by weight, smoking, and physical activity status in both genders. The gender-

and race-specific OA prevalence trends by weight, smoking, and physical activity status are presented in Supplementary Tables 2, 3 and 4. The trend of OA prevalence was similar among people with different weight, smoking, and physical activity status. For example, in obese people, significant linear trends were observed among
Non-Hispanic Caucasian men (Plinear trend < 0.0001) and women from Hispanic, Non-Hispanic Caucasian, and
Non-Hispanic African American groups ( Plinear trend ≤ 0.004). Among non-obese people, significant linear trends
in OA prevalence were observed in Non-Hispanic Caucasian men ( Plinear trend = 0.012) and women from Hispanic,
Non-Hispanic Caucasian, and Non-Hispanic African American groups (Plinear trend ≤ 0.0003).

Multivariable‑adjusted OA prevalence. The odds ratio from age-adjusted and multiple adjusted models
by gender are shown in Table 2. For men, relative to 2005–2006, the positive associations were observed between
age-adjusted OA prevalence and three survey cycles, including 2013–2014 (OR, 1.78; 95% CI 1.42–2.24), 2015–
2016 (OR, 1.36; 95% CI 1.03–1.79), and 2017–2018 (OR, 1.46; 95% CI 1.05–2.02). The linear trend of OA prevalence in men across survey cycles was significant (Plinear trend = 0.0012). For women, the positive associations
were found between age-adjusted OA prevalence and the last four survey cycles, the ORs were 1.41 (95% CI
1.11–1.80) in 2011–2012, 1.88 (95% CI 1.52–2.32) in 2013–2014, 1.70 (95% CI 1.39–2.08) in 2015–2016, and
1.76 (95% CI 1.31–2.35) in 2017–2018, respectively. The linear trend of OA prevalence in women across survey
cycles was significant as well (Plinear trend = 0.0002). Additionally, we observed a significant linear trend of OA
prevalence in men (Plinear trend = 0.009) and women ( Plinear trend < 0.0001) after adjusting for age, race, educational
attainment, PIR, weight status, smoking status, and physical activity.

Discussion

In this study, with data from a nationally representative sample of US residents in noninstitutionalized populations, we found that women had a higher age-adjusted OA prevalence than men. In addition, significant linear
trends and positive slope values of both genders indicate that the OA prevalence increased during 2005–2018. The
increasing linear trend in OA prevalence in both genders still remained significant, even after additional adjustments were made in race/ethnicity, educational attainment, and PIR. Moreover, we found statistically significant
linear trends in age-adjusted OA prevalence in Non-Hispanic Caucasian and Non-Hispanic African Americans
of both genders and in Hispanic women. However, people with lower SES/educational attainment and low PIR
reported a lower age-adjusted OA prevalence than people with higher SES. Also, we observed significant linear
trends of OA prevalence in most SES subgroups for both genders (all Plinear trend ≤ 0.04).
The observed trends in OA prevalence among US adults during 2005–2018 were consistent with the study
conducted by Dr. Park, which found that the age-adjusted prevalence of OA increased during 1999–20147. Since
obesity is a prominent risk factor for OA19, the increasing prevalence of this condition among adults in the US
might contribute to the rising age-adjusted OA prevalence t rend28. In our study, the percentage of obesity in
both genders increased during 2005–2018, corresponding to the observed increasing OA prevalence trend.
Furthermore, our findings regarding a higher prevalence of OA in women than in men also correspond to a
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prior meta-analysis study which found that women are generally at a higher risk of OA than m
 en29. Joint space
narrowing (JSN) is attributed to the loss of articular cartilage and leads to OA30, and women typically have a
significantly more progressive decline in joint space than m
 en31. Thus, the gender difference of JSN might partially
explain the difference in OA prevalence between men and women. In both men and women, the significant linear
trend in OA prevalence still exists after multiple adjustments for age, race/ethnicity, educational attainment, PIR,
obesity, smoking, and physical activity. Apparently, changes in the distribution of these risk factors cannot fully
explain the trend of OA prevalence over the years. In a study by Dr. Dillon et al. in 1991–1994, Non-Hispanic
African Americans were reported to have a higher prevalence of knee OA than Non-Hispanic Caucasians.
African Americans were more likely to have tibiofemoral joint (part of the knee) OA than Caucasians32, thus
indicating that African Americans had a higher knee OA prevalence than Caucasians. However, in the present
study, NHANES did not have information regarding that region of OA. Because our analysis used self-reported
OAs, which includes OA in any joints, we could only analyze the prevalence of self-reported OA in any joints.
Therefore, our results are different from Dr. Dillon’s observations. Caucasians were more likely to have OA on
the spine33, hand, and other regions than African Americans34. In the present study, Caucasians had a higher
OA prevalence than African Americans. Notably, we found that age-adjusted OA prevalence was lower among
people with disadvantaged SES than people with higher SES. These findings were partially consistent with Dr.
Park’s findings that OA was more prevalent in older Non-Hispanic Caucasian women with high family income
or a college degree7. SES is an important determinant of access to healthcare35. People with higher SES are more
likely to have better insurance coverage for accessing healthcare professionals and will presumably obtain more
accurate diagnoses than those with low SES. In the current study, individuals with low SES might lack access to
adequate healthcare for OA diagnosis, leading to lower self-reported OA prevalence in that particular group.
There are several limitations to this study. First, self-report data of doctor diagnosis were used to define OA
in this study because radiographic data were unavailability in NHANES. Also, recall bias possibly impacts the
accuracy of prevalence estimates. However, the CDC recommends using self-reported, doctor-diagnosed arthritis
as the case definition in estimating the prevalence of arthritis36. Studies28 have proven the validity and reliability
of such self-reported data. Second, a small percentage of NHANES participants lack valid information about
educational attainment and thus were not eligible for the analysis. In the current study, 0.1% and 9.1% of eligible
subjects lacked information about education level and family income, respectively, thus possibly leading to a
biased estimate. Third, non-response bias is always a concern in NHANES data, as response rates have declined
in federal surveys since 200037. The decline in response rates could have a different impact on OA’s estimated
prevalence accuracy across the different survey cycles we studied. However, the sample weights of NHANES
have accounted for non-response in the analysis. Therefore, these limitations are unlikely to have altered the
trends of OA prevalence we observed.

Conclusion

In summary, an increasing trend in OA’s age-adjusted prevalence was observed among US men and women
during 2005–2018. Non-Hispanic Caucasian and Non-Hispanic African Americans had significantly increasing linear trends in OA prevalence in both genders. People with disadvantaged SES had a lower prevalence of
OA. Considering the work limitations and economic burden caused by OA, our findings may be informative in
developing related policies to reduce disease development among the population and reduce related risk factors.
Our results of OA disparities suggest a need to increase public and health system awareness of OA, especially
in Non-Hispanic Caucasian and Non-Hispanic African Americans. Additional research is warranted to further
explain the increasing trend in OA prevalence in different races/ethnicities and SES groups in order to more
accurately determine the most effective strategies for preventing OA and reducing such glaring disparities.
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